CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

New report

Provides comprehensive understanding and unprecedented access to the  clinical stage partnering agreements deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Sutro and Celgene sign a pharma deal for $1 billion

October 24, 2014 : big pharma, Celgene, pharma licensing, pharma partnering

Sutro Biopharma has entered a pharma deal and option agreement with Celgene to discover and develop antibodies and antibody drug conjugates. more »

IMS health and UCB form a pharma partnership

October 23, 2014 : pharma alliances, pharma licensing, pharma partnering, UCB

IMS Health becomes pharma partner with UCB to help deliver greater business insights and improved operations, leveraging IMS Health’s Nexxus Commercial Application Suite and the IMS One intelligent cloud. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Actavis to acquire Rhythm Health for $40 million

October 23, 2014 :

Actavis announced that Actavis has been granted an exclusive option to acquire Rhythm Health. more »

Morphosys acquires lanthipeptide technology from Lanthio Pharma

October 16, 2014 : acquisition, asset purchase, big biotech, MorphoSys, technology

MorphoSys and Lanthio Pharma acquires of Lanthio Pharma’s lanthipeptide technology, which will be used for drug discovery by MorphoSys. more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Telcare has raised a Series C round of financing of $32.5 million

October 24, 2014 : financing, financings, medical device

Telcare has raised a Series C round of financing of $32.5 million. more »

Erytech raises $37 million in public offering financing

October 24, 2014 : financing, financings

ERYTECH develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical need, announces the successful completion of a capital financing increase for a total amount of €30 million ($37.96 million). more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Both, Actavis and Sanofi competing for Omega Pharma

October 22, 2014 : Actavis, Sanofi

Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland. more »

AbbVie rethinking the $54 billion acquisition of Shire

October 16, 2014 : AbbVie, acquisition, shire

In response to recent changes to the U.S. tax code to discourage so-called tax inversion deals, Chicago-based AbbVie recently indicated it was rethinking its $54 billion takeover bid of U.K.-based Shire. more »

 More dealtalk

Featured reports

Global Joint Venture Partnerships

Publication date: October 2014

Top 50 Big Pharma Partnering and M&A

Publication date: October 2014

Bioinformatics Partnering Terms and Agreements

Publication date: October 2014

Top 50 Big Biotech Partnering and M&A

Publication date: October 2014

Molecular Diagnostics Partnering Terms and Agreements

Publication date: October 2014

Regenerative Medicine Partnering Terms and Agreements

Publication date: October 2014

Discovery Stage Partnering Terms and Agreements

Publication date: September 2014

Preclinical Stage Partnering Terms and Agreements

Publication date: September 2014

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Diagnostic Imaging Partnering Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
bannerpng
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new1gif
e56300x150animgif
currentpartneringpharma-bio300x150gif